Journal of the Chinese Medical Association : JCMA最新文献

筛选
英文 中文
Does "the different study period" influence outcome evaluation? 研究时间不同 "会影响结果评估吗?
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-11-01 Epub Date: 2024-08-26 DOI: 10.1097/JCMA.0000000000001161
Yiu-Tai Li, Wen-Hsun Chang
{"title":"Does \"the different study period\" influence outcome evaluation?","authors":"Yiu-Tai Li, Wen-Hsun Chang","doi":"10.1097/JCMA.0000000000001161","DOIUrl":"10.1097/JCMA.0000000000001161","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"1029"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: "Does 'the different study period' influence outcome evaluation?" 答复"研究时间不同 "会影响结果评估吗?
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-11-01 Epub Date: 2024-08-26 DOI: 10.1097/JCMA.0000000000001160
Chih-Hsien Chang, Shih-Ching Chang, Jeng-Kai Jiang, Huann-Sheng Wang, Yuan-Tzu Lan, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Hou-Hsuan Cheng, Yi-Wen Yang, Yu-Zu Lin
{"title":"Reply to: \"Does 'the different study period' influence outcome evaluation?\"","authors":"Chih-Hsien Chang, Shih-Ching Chang, Jeng-Kai Jiang, Huann-Sheng Wang, Yuan-Tzu Lan, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Hou-Hsuan Cheng, Yi-Wen Yang, Yu-Zu Lin","doi":"10.1097/JCMA.0000000000001160","DOIUrl":"10.1097/JCMA.0000000000001160","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"1030"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparable efficacy and safety for bicuspid aortic valve stenosis patients undergoing transcatheter aortic valve replacement with balloon-expandable or self-expanding valves using Wei's sizing method. 对接受经导管主动脉瓣置换术的双尖瓣主动脉瓣狭窄患者,使用球囊扩张瓣膜或自扩张瓣膜的疗效和安全性具有可比性。
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-11-01 Epub Date: 2024-08-20 DOI: 10.1097/JCMA.0000000000001155
Yung-Tsai Lee, Wei-Hsian Yin, Tien-Ping Tsao, Kuo-Chen Lee, Huan-Chiu Lin, Chun-Ting Liu, Ming-Chon Hsiung, Jeng Wei
{"title":"Comparable efficacy and safety for bicuspid aortic valve stenosis patients undergoing transcatheter aortic valve replacement with balloon-expandable or self-expanding valves using Wei's sizing method.","authors":"Yung-Tsai Lee, Wei-Hsian Yin, Tien-Ping Tsao, Kuo-Chen Lee, Huan-Chiu Lin, Chun-Ting Liu, Ming-Chon Hsiung, Jeng Wei","doi":"10.1097/JCMA.0000000000001155","DOIUrl":"10.1097/JCMA.0000000000001155","url":null,"abstract":"<p><strong>Background: </strong>The present study aimed to investigate whether proper sizing can improve the procedural and clinical outcomes of transcatheter aortic valve replacement (TAVR) with new-generation self-expanding valves (SEVs) and balloon-expandable valves (BEVs) for treating bicuspid aortic stenosis (BAS).</p><p><strong>Methods: </strong>We retrospectively evaluated consecutive patients who underwent TAVR with Sapien 3 valves (Edwards Lifesciences, Irvine, CA) or Evolut R/PRO valves (Medtronic, Minneapolis, MN) for severe BAS from 2017 to 2022. The primary endpoints were device success rate and major adverse cardiac and cerebral events (MACCEs), including mortality, nonfatal myocardial infarction or disabling stroke, transcatheter heart valve failure, or clinically relevant valve thrombosis during follow-up. Our team used a complementary approach of supraannular sizing in addition to the conventional annular sizing method (Wei's method) to guide the TAVR procedures.</p><p><strong>Results: </strong>We recruited a total of 75 consecutive patients, of whom 43 (57%) were treated with BEVs from October 2017 to June 2021, and 32 (43%) were treated with SEVs from July 2021 to December 2022. Device success was similar between the BEV and SEV groups (93% vs 94%; p > 0.99), and no cases of annular rupture occurred in either group. Similar rates of moderate-to-severe paravalvular leak were observed in the BEV and SEV groups (5% vs 6%, p > 0.99). At a median follow-up of 464 days, the MACCE rates were comparable between the two groups. In multivariate analysis, the presence of previous percutaneous coronary interventions (hazard ratio: 5.43; p = 0.039) and New York Heart Association functional class III/IV heart failure at 30 days of follow-up after TAVR (hazard ratio: 9.90; p = 0.037) were independently associated with long-term MACCEs.</p><p><strong>Conclusion: </strong>Our results demonstrated comparable efficacy and safety for BAS patients undergoing TAVR using either BEVs or SEVs when using Wei's sizing method.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"993-1001"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant therapy and locally advanced cancer diseases. 新辅助治疗和局部晚期癌症疾病。
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-11-01 Epub Date: 2024-08-21 DOI: 10.1097/JCMA.0000000000001157
Peng-Hui Wang, Szu-Ting Yang
{"title":"Neoadjuvant therapy and locally advanced cancer diseases.","authors":"Peng-Hui Wang, Szu-Ting Yang","doi":"10.1097/JCMA.0000000000001157","DOIUrl":"10.1097/JCMA.0000000000001157","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"969-971"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142010167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world risk factors for herpes zoster in patients with rheumatoid arthritis undergoing tofacitinib treatment. 接受托法替尼治疗的类风湿性关节炎患者发生带状疱疹的现实风险因素。
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-11-01 Epub Date: 2024-08-26 DOI: 10.1097/JCMA.0000000000001159
Yi-Syuan Sun, De-Feng Huang, Wei-Sheng Chen, Hsien-Tzung Liao, Ming-Han Chen, Hung-Cheng Tsai, Ming-Tsun Tsai, Chang-Youh Tsai, Chien-Chih Lai, Chih-Yu Yang
{"title":"Real-world risk factors for herpes zoster in patients with rheumatoid arthritis undergoing tofacitinib treatment.","authors":"Yi-Syuan Sun, De-Feng Huang, Wei-Sheng Chen, Hsien-Tzung Liao, Ming-Han Chen, Hung-Cheng Tsai, Ming-Tsun Tsai, Chang-Youh Tsai, Chien-Chih Lai, Chih-Yu Yang","doi":"10.1097/JCMA.0000000000001159","DOIUrl":"10.1097/JCMA.0000000000001159","url":null,"abstract":"<p><strong>Background: </strong>This study sought to assess the risk factors of herpes zoster (HZ) in rheumatoid arthritis (RA) patients treated with tofacitinib (TOFA).</p><p><strong>Methods: </strong>This retrospective study reviewed RA patients receiving TOFA. We compared clinical characteristics, laboratory profiles, concomitant medication use, and HZ incidence in patients with and without recent biologic synthetic disease-modifying antirheumatic drugs (bDMARDs) treatment, which is defined as their administration ≤180 days before the initiation of TOFA treatment. We used univariate Cox proportional hazards models and Kaplan-Meier analysis to assess risk factors.</p><p><strong>Results: </strong>Among 304 RA patients, 97 had recent bDMARDs use and 207 did not. Patients with recent bDMARDs use typically had lower weekly doses of methotrexate, less hydroxychloroquine use, and shorter follow-up. In the recent bDMARDs group, 64 (66.0%) used tumor necrosis factor inhibitors (TNFi), 19 (19.6%) used tocilizumab, and 14 (14.4%) used abatacept. The overall incidence rate (IR) of HZ was 5.62 per 100 person-years. Patients with recent bDMARDs use exhibited a higher HZ risk compared to those without recent bDMARDs use (IR ratio: 2.34, 95% CI, 1.04-5.19, p = 0.028). Recent bDMARDs use (hazard ratio: 2.4, 95% CI, 1.12-4.95, p = 0.024) was an independent risk factor for HZ among multivariable analysis. Kaplan-Meier analysis confirmed increased HZ risk in RA patients on TOFA with recent bDMARDs use (log-rank p = 0.015).</p><p><strong>Conclusion: </strong>HZ is common in RA patients treated with TOFA, and recent bDMARDs (TNFi, tocilizumab, and abatacept) use is a risk factor for HZ. HZ vaccination, therefore, should be recommended for this group.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"988-992"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is pancreaticoduodenectomy justified for metastatic melanoma to the ampulla of Vater? 胰十二指肠切除术对瓦特氏管转移性黑色素瘤是否合理?
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-10-24 DOI: 10.1097/JCMA.0000000000001185
Chieh-Ning Hsi, Shin-E Wang, Bor-Shiuan Shyr, Shih-Chin Chen, Yi-Ming Shyr, Bor-Uei Shyr
{"title":"Is pancreaticoduodenectomy justified for metastatic melanoma to the ampulla of Vater?","authors":"Chieh-Ning Hsi, Shin-E Wang, Bor-Shiuan Shyr, Shih-Chin Chen, Yi-Ming Shyr, Bor-Uei Shyr","doi":"10.1097/JCMA.0000000000001185","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001185","url":null,"abstract":"<p><strong>Background: </strong>Metastatic melanoma of the ampulla of Vater is rare. The purpose of this study was to summarize the characteristics and outcomes of metastatic melanoma in the ampulla of Vater and highlight the impact of surgery on the prognosis of patients with metastatic melanoma.</p><p><strong>Methods: </strong>Pooled data from a case encountered at our institution and from all sporadic cases published on PubMed and MEDLINE between 1996 and 2023 were analyzed.</p><p><strong>Results: </strong>Fourteen patients with metastatic melanoma in the ampulla of Vater were enrolled. Seventy-three percent of primary melanomas were cutaneous and 27% were mucosal. Jaundice was the most common symptom (86%). The size of metastatic melanoma to the ampulla ranged from 1.5 cm to 8 cm, with a median of 2.75 cm. Concomitant metastasis to other organs occurred in 82% of the patients at the time of diagnosis, most commonly in the brain, lungs, and liver (36% each). Among the reported cases, pancreaticoduodenectomy was performed in five patients. The overall 1-year survival rate was 27.3%, with a median survival of four months. Wide excision of the primary lesion and chemotherapy significantly improved survival rates (p= 0.048). There is a trend toward improved survival in patients undergoing pancreaticoduodenectomy followed by chemotherapy.</p><p><strong>Conclusion: </strong>Given the availability of effective systemic therapies, metastatic melanoma of the ampulla of Vater does not necessarily preclude major surgeries.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part VI. 中华医学会台北年会 2023 年度优秀荣誉奖获奖者:第六部分.
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-10-01 Epub Date: 2024-08-02 DOI: 10.1097/JCMA.0000000000001140
Peng-Hui Wang, Wen-Hsun Chang
{"title":"Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part VI.","authors":"Peng-Hui Wang, Wen-Hsun Chang","doi":"10.1097/JCMA.0000000000001140","DOIUrl":"10.1097/JCMA.0000000000001140","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"901-903"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part V. 中华医学会台北年会 2023 年度优秀荣誉奖获奖者:第五部分.
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-10-01 Epub Date: 2024-08-05 DOI: 10.1097/JCMA.0000000000001139
Chia-Hao Liu, Peng-Hui Wang
{"title":"Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part V.","authors":"Chia-Hao Liu, Peng-Hui Wang","doi":"10.1097/JCMA.0000000000001139","DOIUrl":"10.1097/JCMA.0000000000001139","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"899-900"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141891442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associated factors of osteoporosis in Chinese patients with rheumatoid arthritis: A systematic review and meta-analysis. 中国类风湿关节炎患者骨质疏松症的相关因素:系统回顾与荟萃分析
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1097/JCMA.0000000000001144
Zhiming Song, Liangliang Fan, Hongyan Wang, Jun Cao, Zhifei Wen, Yanmin Tao, Xiangeng Zhang
{"title":"Associated factors of osteoporosis in Chinese patients with rheumatoid arthritis: A systematic review and meta-analysis.","authors":"Zhiming Song, Liangliang Fan, Hongyan Wang, Jun Cao, Zhifei Wen, Yanmin Tao, Xiangeng Zhang","doi":"10.1097/JCMA.0000000000001144","DOIUrl":"10.1097/JCMA.0000000000001144","url":null,"abstract":"<p><strong>Background: </strong>The aim of this systematic review and meta-analysis was to analyze the factors associated of osteoporosis in patients with rheumatoid arthritis (RA) in China.</p><p><strong>Methods: </strong>PubMed, Embase, Web of Science, Cochrane Library, CINAHL, and four Chinese electronic databases were searched for observational studies without language restrictions that reported the factors associated of osteoporosis from inception to February 2023. A modified Newcastle-Ottawa Scale evaluated the risk of bias. Statistical heterogeneity among the included studies was analyzed using Cochran Q and I2 tests. Begg and Egger tests were used to assess the publication bias.</p><p><strong>Results: </strong>A total of 15 studies were finally included. The meta-analysis showed that 10 factors were grouped into three themes with statistical significance: (1) demographics theme: age ≥50 (odds ratio [OR] = 1.161; 95% CI, 1.111-1.231; p < 0.001), low body mass index (BMI) (OR = 1.248; 95% CI, 1.192-1.312; p < 0.001), female (OR = 5.174; 95% CI, 3.058-7.290; p < 0.001), and menopause (OR = 4.917; 95% CI, 1.558-15.523; I2 = 0.0%; p = 0.007); (2) RA-related factor theme: disease duration (OR = 1.083; 95% CI, 1.038-1.127; p < 0.001), and glucocorticoids (OR = 2.740; 95% CI, 2.000-3.750; p < 0.001); (3) relevant physiological indicators or scores theme: low 25(OH)D 3 (OR = 1.009; 95% CI, 1.003-1.016; p < 0.001), erythrocyte sedimentation rate (ESR) (OR = 1.489; 95% CI, 1.041-2.130; p = 0.029), high Disease Activity Score in 28 joints (DAS28) score (OR = 2.5991; 95% CI, 1.094-6.138; p < 0.001); and β-isomerized C-terminal telopeptide (β-CTx) (OR = 1.009; 95% CI, 1.003-1.016; p = 0.005).</p><p><strong>Conclusion: </strong>Osteoporosis in patients with RA is associated with various factors. Therefore, patients with RA should be monitored in a timely manner and targeted interventions should be taken. In addition, further longitudinal studies are needed to confirm the direct link between multiple factors and osteoporosis.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"953-960"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of low-dose ketamine on electroencephalographic spectrum during gynecology surgery under desflurane anesthesia. 地氟醚麻醉下小剂量氯胺酮对妇科手术中脑电频谱的影响
Journal of the Chinese Medical Association : JCMA Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1097/JCMA.0000000000001142
Yu-Pin Huang, Shih-Pin Lin, Huann-Cheng Horng, Wen-Kuei Chang, Cheng-Ming Tsao
{"title":"The effect of low-dose ketamine on electroencephalographic spectrum during gynecology surgery under desflurane anesthesia.","authors":"Yu-Pin Huang, Shih-Pin Lin, Huann-Cheng Horng, Wen-Kuei Chang, Cheng-Ming Tsao","doi":"10.1097/JCMA.0000000000001142","DOIUrl":"10.1097/JCMA.0000000000001142","url":null,"abstract":"<p><strong>Background: </strong>The perioperative administration of low-dose ketamine has shown potential in postoperative pain management, opioid sparing, and enhancing pain control. This study aimed to investigate the impact of low-dose ketamine on processed electroencephalography (EEG) signals during anesthesia.</p><p><strong>Methods: </strong>Forty patients with American Society of Anesthesiologists physical status I-II undergoing elective gynecological surgery were enrolled. EEG monitoring was initiated upon induction of anesthesia. Anesthesia was maintained with desflurane and alfentanil immediately after induction. Fifteen minutes after induction, the ketamine group received a 0.3 mg/kg bolus followed by 0.05 mg/kg/h infusion until completion of surgery. The control group received equivalent saline. Postoperative assessments included pain score (visual analog scale), morphine usage, and quality of recovery.</p><p><strong>Results: </strong>The ketamine group had significantly higher Patient State Index (PSi) values at 10, 20, and 30 minutes after ketamine administration compared to the controls. Ketamine administration led to significant alterations in EEG patterns, including reduced relative power in delta and theta frequency bands, and increased relative power in beta and gamma frequency bands at 10 minutes post-administration. Relative power in the alpha frequency band significantly decreased at 10, 20, and 30 minutes post-administration. However, there were no differences in intraoperative alfentanil consumption, postoperative morphine usage, and pain scores between the two groups.</p><p><strong>Conclusion: </strong>Low-dose ketamine administration during desflurane anesthesia led to notable changes in EEG patterns and PSi values. These findings provide valuable insights into the impact of ketamine on brain activity, and offer essential information for clinical anesthesiologists.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"933-939"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信